Prevalence of zinc transporter 8 antibodies in gestational diabetes mellitus

Diabetic Medicine

Volumn 29, Issue 12, 2012, Pages

  Dereke, J ^a   Nilsson, C ^a,b   Landin Olsson, M ^a,b   Hillman, M ^a  

^a LUND UNIVERSITY   (Sweden)

^b HELSINGBORG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE; PROTEIN TYROSINE PHOSPHATASE; TYROSINE PHOSPHATASE LIKE PROTEIN; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8 ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS;

ADULT; AUTOANTIBODIES; C-PEPTIDE; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; GLUTAMATE DECARBOXYLASE; HUMANS; INCIDENCE; INSULIN-SECRETING CELLS; PILOT PROJECTS; PREGNANCY; SWEDEN;

EID: 84869106655     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03766.x     Document Type: Article

References (18)

1. Wenzlau JM, Frisch LM, Gardner TJ, Sarkar S, Hutton JC, Davidson HW. Novel antigens in type1 diabetes: the importance of ZnT8. Curr Diab Rep 2009; 9: 105-112.
2. Wenzlau JM, Liu Y, Yu L, Moua O, Fowler KT, Rangasamy S et al. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type1 diabetes. Diabetes 2008; 57: 2693-2697.
3. Lampasona V, Schlosser M, Mueller PW, Williams AJK, Wenzlau JM, Hutton JC et al. Diabetes Antibody Standardization Program: first proficiency evaluation of assays for autoantibodies to zinc transporter8. Clin Chem 2011; 57: 1693-1702.
4. Achenbach P, Lampasona V, Landherr U, Koczwara K, Krause S, Grallert H et al. Autoantibodies to zinc transporter8 and SLC30A8 genotype stratify type1 diabetes risk. Diabetologia 2009; 52: 1881-1888.
5. Yang L, Luo S, Huang G, Peng J, Li X, Yan X et al. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type1 diabetes in Chinese. Diabetes Metab Res Rev 2010; 26: 579-584.
6. De Grijse J, Asanghanwa M, Nouthe B, Albrecher N, Goubert P, Vermeulen I et al. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2β) and zinc transporter-8 to select first-degree relatives of type1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. Diabetologia 2010; 53: 517-524.
7. Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, di Pietro S et al. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes non-insulin requiring autoimmune diabetes (NIRAD) 4. Diabetes Care 2010; 33: 104-108.
8. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type1 diabetes. Proc Natl Acad Sci 2007; 104: 17040-17045.
9. Dang M, Rockell J, Wagner R, Wenzlau JM, Yu L, Hutton JC et al. Human Type1 diabetes is associated with T-cell autoimmunity to zinc transporter8. J Immunol 2011; 180: 6056-6063.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34: S62-S69.
11. Aberg A, Rydhstroem H, Frid A. Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden. Am J Obstet Gynecol 2001; 184: 77-83.
12. Schmidt MI, Duncan BB, Reichelt AJ, Branchtein L, Matos MC, Costa e Forti A et al. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 2001; 24: 1151-1155.
13. Buchanan TA, Kjos SL. Gestational diabetes: risk or myth?J Clin Endocrinol Metab 1999; 84: 1854-1857.
14. Järvelä IY, Juutinen J, Koskela P, Hartikainen A-L, Kulmala P, Knip M et al. Gestational diabetes identifies women at risk for permanent type1 and type2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care 2006; 29: 607-612.
15. Nilsson C, Ursing D, Törn C, Aberg A, Landin-Olsson M. Presence of GAD antibodies during gestational diabetes mellitus predicts type1 diabetes. Diabetes Care 2007; 30: 1968-1971.
16. Fuchtenbusch M, Ferber K, Standl E, Ziegler AG. Prediction of type1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes 1997; 46: 1459-1467.
17. Damm P, Kühl C, Buschard K, Jakobsen BK, Svejgaard A, Sodoyez-Goffaux F et al. Prevalence and predictive value of islet cell antibodies and insulin autoantibodies in women with gestational diabetes. Diabet Med 1994; 11: 558-563.
18. Fuchtenbusch M, Bonifacio E, Lampasona V, Knopff A, Ziegler A. Immune responses to glutamic acid decarboxylase and insulin in patients with gestational diabetes. Clin Exp Immunol 2004; 135: 318-321.